Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 1
2006 2
2007 10
2008 10
2009 10
2010 9
2011 18
2012 16
2013 14
2014 23
2015 26
2016 37
2017 44
2018 44
2019 51
2020 60
2021 84
2022 87
2023 90
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

360 results

Results by year

Filters applied: Systematic Review, in the last 5 years. Clear all
Page 1
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People with Obesity or Overweight: A Systematic Review.
Xie Z, Yang S, Deng W, Li J, Chen J. Xie Z, et al. Clin Epidemiol. 2022 Dec 6;14:1463-1476. doi: 10.2147/CLEP.S391819. eCollection 2022. Clin Epidemiol. 2022. PMID: 36510488 Free PMC article. Review.
Semaglutide 2.4mg has an absolute advantage in weight loss and decreased HbA1c, but the incidence of total adverse events is also the highest and can cause hypoglycemia. In addition, although liraglutide 3.0mg was less effective than semaglutide 2.4mg, serious adverse even …
Semaglutide 2.4mg has an absolute advantage in weight loss and decreased HbA1c, but the incidence of total adverse events is also the highes …
Hypoglycemia in Pregnancies Following Gastric Bypass-a Systematic Review and Meta-analysis.
Stentebjerg LL, Madsen LR, Støving RK, Juhl CB, Vinter CA, Andersen LLT, Renault K, Jensen DM. Stentebjerg LL, et al. Obes Surg. 2022 Jun;32(6):2047-2055. doi: 10.1007/s11695-022-06021-z. Epub 2022 Mar 24. Obes Surg. 2022. PMID: 35332397 Review.
As assessed by the oral glucose tolerance test and continuous glucose monitoring, 57.6% (95% CI [40.1, 75.1]) of women with gastric bypass were exposed to hypoglycemia during pregnancy. No studies performed the mixed meal test, and no studies reported on risk factors assoc …
As assessed by the oral glucose tolerance test and continuous glucose monitoring, 57.6% (95% CI [40.1, 75.1]) of women with gastric bypass w …
GLP-1 agonists for obesity and type 2 diabetes in children: Systematic review and meta-analysis.
Chadda KR, Cheng TS, Ong KK. Chadda KR, et al. Obes Rev. 2021 Jun;22(6):e13177. doi: 10.1111/obr.13177. Epub 2020 Dec 22. Obes Rev. 2021. PMID: 33354917 Review.
Adverse effects included gastrointestinal symptoms and minor hypoglycemic episodes, but not severe hypoglycemia. GLP-1 agonists are efficacious in treating children with obesity and/or T2DM. ...
Adverse effects included gastrointestinal symptoms and minor hypoglycemic episodes, but not severe hypoglycemia. GLP-1 agonists are e …
Hypoglycemia and mortality in sepsis patients: A systematic review and meta-analysis.
Wang J, Zhu CK, Yu JQ, Tan R, Yang PL. Wang J, et al. Heart Lung. 2021 Nov-Dec;50(6):933-940. doi: 10.1016/j.hrtlng.2021.07.017. Epub 2021 Aug 22. Heart Lung. 2021. PMID: 34433111 Review.
BACKGROUND: Hypoglycemia frequently occurs in patients with sepsis. The status of prognosis of sepsis patients varies with the cause of hypoglycemia. ...Incidents of mortality were analyzed based on the causative factor of hypoglycemia. Patients with spontane …
BACKGROUND: Hypoglycemia frequently occurs in patients with sepsis. The status of prognosis of sepsis patients varies with the cause …
Type 1 Diabetes Hypoglycemia Prediction Algorithms: Systematic Review.
Tsichlaki S, Koumakis L, Tsiknakis M. Tsichlaki S, et al. JMIR Diabetes. 2022 Jul 21;7(3):e34699. doi: 10.2196/34699. JMIR Diabetes. 2022. PMID: 35862181 Free PMC article. Review.
Nonetheless, a loose glycemic control might increase the risk of developing hypoglycemia. This incident can occur because of a variety of causes, such as taking additional doses of insulin, skipping meals, or overexercising. Mainly, the symptoms of hypoglycemia rang …
Nonetheless, a loose glycemic control might increase the risk of developing hypoglycemia. This incident can occur because of a variet …
Once-weekly basal insulin icodec: Looking ONWARDS from pharmacology to clinical trials.
Singh AK, Singh A, Singh R, Misra A. Singh AK, et al. Diabetes Metab Syndr. 2022 Sep;16(9):102615. doi: 10.1016/j.dsx.2022.102615. Epub 2022 Sep 7. Diabetes Metab Syndr. 2022. PMID: 36108418 Review.
Phase 2 studies compared once-weekly icodec to insulin glargine (U-100) and found a similar glucose control with no significantly greater hypoglycemia risks. Top-line results from the five phase 3 studies reported better glucose control with once-weekly icodec compared to …
Phase 2 studies compared once-weekly icodec to insulin glargine (U-100) and found a similar glucose control with no significantly greater …
Prevalence and impact of polypharmacy in older patients with type 2 diabetes.
Remelli F, Ceresini MG, Trevisan C, Noale M, Volpato S. Remelli F, et al. Aging Clin Exp Res. 2022 Sep;34(9):1969-1983. doi: 10.1007/s40520-022-02165-1. Epub 2022 Jun 20. Aging Clin Exp Res. 2022. PMID: 35723858 Free PMC article. Review.
Across the selected studies, polypharmacy seemed to negatively influence both diabetes-specific (poor glycemic control and risk of hypoglycemia) and health-related (risk of incident falls, syncope, hospitalization, and death) outcomes. ...
Across the selected studies, polypharmacy seemed to negatively influence both diabetes-specific (poor glycemic control and risk of hypogl
Identifying Patients With Hypoglycemia Using Natural Language Processing: Systematic Literature Review.
Zheng Y, Dickson VV, Blecker S, Ng JM, Rice BC, Melkus GD, Shenkar L, Mortejo MCR, Johnson SB. Zheng Y, et al. JMIR Diabetes. 2022 May 16;7(2):e34681. doi: 10.2196/34681. JMIR Diabetes. 2022. PMID: 35576579 Free PMC article. Review.
Keywords included hypoglycemia, low blood glucose, NLP, and machine learning. Inclusion criteria included studies that applied NLP to identify hypoglycemia, reported the outcomes related to hypoglycemia, and were published in English as full papers. RESULTS: …
Keywords included hypoglycemia, low blood glucose, NLP, and machine learning. Inclusion criteria included studies that applied NLP to …
The risk factors of inpatient hypoglycemia: A systematic review.
Pratiwi C, Mokoagow MI, Made Kshanti IA, Soewondo P. Pratiwi C, et al. Heliyon. 2020 May 11;6(5):e03913. doi: 10.1016/j.heliyon.2020.e03913. eCollection 2020 May. Heliyon. 2020. PMID: 32420485 Free PMC article. Review.
Hypoglycemia can be divided into two types, i.e. primary hypoglycemia when hypoglycemia is the main diagnosis for admission, whereas secondary hypoglycemia if hypoglycemia occurs during hospitalization. ...The incidence of inpatient hypoglyce
Hypoglycemia can be divided into two types, i.e. primary hypoglycemia when hypoglycemia is the main diagnosis for admis
Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis.
Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, Xu N, Hou K, Hu Z, Chen Y, Chen R. Xie W, et al. Front Pharmacol. 2022 Nov 16;13:1015045. doi: 10.3389/fphar.2022.1015045. eCollection 2022. Front Pharmacol. 2022. PMID: 36467075 Free PMC article.
However, traditional insulin secretory agents such as sulfonylureas and glinides have side effects of hypoglycemia. In recent years, researchers have discovered that berberine can inhibit the voltage-gated k(+) channels of pancreatic beta cell membrane and promote insulin …
However, traditional insulin secretory agents such as sulfonylureas and glinides have side effects of hypoglycemia. In recent years, …
360 results